Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.
There is currently no completely effective therapy available for metastatic pheochromocytomas or paragangliomas. Increasing understanding of the germline and somatic mutations leading to pheochromocytoma and paraganglioma development has revealed crucial insights into the molecular pathology of thes...
Главные авторы: | Nölting, S, Grossman, AB |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
2012
|
Схожие документы
-
Pheochromocytomas and paragangliomas: assessment of malignant potential.
по: Korevaar, T, и др.
Опубликовано: (2011) -
Pheochromocytomas and paragangliomas: assessment of malignant potential
по: Korevaar, T, и др.
Опубликовано: (2011) -
Current management of pheochromocytoma/paraganglioma: a guide for the practicing clinician in the era of precision medicine
по: Nölting, S, и др.
Опубликовано: (2019) -
Pheochromocytomas and secreting paragangliomas
по: Gimenez-Roqueplo Anne-Paule, и др.
Опубликовано: (2006-12-01) -
Treatment of metastatic pheochromocytoma and paraganglioma with I-131-meta-iodobenzylguanidine (MIBG)
по: Kaltsas, G, и др.
Опубликовано: (2003)